The University of Chicago Header Logo

Justin P. Kline

Concepts (290)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
10
2019
763
1.440
Why?
Hematopoietic Stem Cell Transplantation
16
2023
878
1.410
Why?
Programmed Cell Death 1 Receptor
7
2023
159
1.360
Why?
Immunotherapy
8
2023
631
1.350
Why?
T-Lymphocytes, Regulatory
4
2016
296
1.120
Why?
Immune Tolerance
5
2017
337
1.080
Why?
T-Lymphocytes
11
2021
1200
1.070
Why?
Antibodies, Monoclonal
7
2023
1380
0.970
Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
151
0.960
Why?
B7-H1 Antigen
6
2020
250
0.950
Why?
Transplantation Conditioning
13
2020
373
0.940
Why?
Lymphoma
4
2020
262
0.920
Why?
Hodgkin Disease
2
2017
177
0.870
Why?
Immunotherapy, Adoptive
3
2021
170
0.840
Why?
Melanoma, Experimental
3
2014
103
0.820
Why?
Tumor Escape
2
2020
49
0.790
Why?
Antigen-Presenting Cells
3
2017
139
0.780
Why?
Graft vs Host Disease
9
2020
365
0.780
Why?
Leukemia
4
2017
320
0.740
Why?
Antineoplastic Agents
10
2023
2360
0.700
Why?
Cell Proliferation
5
2016
1596
0.690
Why?
Homeostasis
3
2012
410
0.690
Why?
Lymphoma, B-Cell
1
2020
103
0.680
Why?
Neoplasms
8
2018
2898
0.670
Why?
Arabinonucleosides
3
2011
39
0.650
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2023
2438
0.600
Why?
Immune Evasion
1
2017
33
0.590
Why?
Transplantation, Homologous
16
2020
996
0.550
Why?
Immunity, Innate
3
2016
410
0.530
Why?
Lymphoma, Non-Hodgkin
4
2013
261
0.530
Why?
Lymphocyte Activation
4
2016
733
0.520
Why?
Hematologic Neoplasms
5
2023
329
0.510
Why?
Lymphocyte Depletion
4
2017
97
0.480
Why?
Thymus Gland
1
2014
195
0.460
Why?
CD40 Antigens
1
2013
43
0.450
Why?
Tumor Microenvironment
4
2023
418
0.450
Why?
Geriatric Assessment
4
2020
166
0.440
Why?
Signal Transduction
5
2017
3267
0.440
Why?
Cross-Priming
1
2012
48
0.410
Why?
Graft vs Tumor Effect
2
2010
25
0.410
Why?
Animals
21
2020
26706
0.400
Why?
Mice, Inbred C57BL
9
2016
3111
0.400
Why?
B7-1 Antigen
3
2016
75
0.400
Why?
Antigen Presentation
3
2020
210
0.390
Why?
Humans
47
2023
86656
0.370
Why?
Adenine Nucleotides
2
2011
63
0.370
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2010
112
0.360
Why?
Cord Blood Stem Cell Transplantation
4
2017
93
0.360
Why?
Antibodies, Neoplasm
2
2009
84
0.350
Why?
Membrane Proteins
1
2016
1201
0.350
Why?
Cell Differentiation
3
2016
1471
0.350
Why?
CD8-Positive T-Lymphocytes
5
2016
560
0.350
Why?
WT1 Proteins
1
2009
19
0.340
Why?
Salvage Therapy
1
2010
233
0.340
Why?
Rituximab
4
2023
116
0.340
Why?
Mice
14
2016
11439
0.330
Why?
Antigens, Differentiation
1
2009
141
0.330
Why?
Cytotoxicity, Immunologic
1
2009
213
0.330
Why?
Mice, Knockout
7
2016
1944
0.310
Why?
Membrane Glycoproteins
1
2009
429
0.290
Why?
Leukemia, T-Cell
1
2006
17
0.290
Why?
CD47 Antigen
2
2016
13
0.280
Why?
Ganciclovir
1
2006
49
0.270
Why?
Flow Cytometry
4
2013
680
0.270
Why?
Valine
1
2006
69
0.270
Why?
Peptides
1
2009
639
0.270
Why?
Acyclovir
1
2006
107
0.270
Why?
Antiviral Agents
2
2007
512
0.260
Why?
Cytomegalovirus Infections
1
2006
144
0.260
Why?
Bone Marrow Transplantation
1
2006
286
0.250
Why?
Middle Aged
23
2019
25027
0.250
Why?
Aged
22
2020
18407
0.250
Why?
Transplantation, Autologous
4
2020
331
0.240
Why?
Survival Analysis
6
2017
1540
0.230
Why?
Interferon Type I
2
2016
175
0.230
Why?
Male
25
2020
40995
0.220
Why?
Lymphoma, Follicular
1
2023
70
0.220
Why?
Self Tolerance
2
2016
24
0.220
Why?
Cell Separation
2
2013
196
0.210
Why?
Antigens, Neoplasm
2
2016
325
0.210
Why?
Antibodies, Monoclonal, Murine-Derived
2
2013
78
0.210
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2005
375
0.200
Why?
Cell Line, Tumor
5
2016
2427
0.200
Why?
Histiocytes
1
2021
22
0.200
Why?
Peripheral Blood Stem Cell Transplantation
2
2012
67
0.200
Why?
Adult
18
2019
25648
0.200
Why?
Antigens, CD19
1
2021
39
0.200
Why?
Disease Models, Animal
3
2016
2243
0.200
Why?
Cell- and Tissue-Based Therapy
1
2021
49
0.200
Why?
Interferon-gamma
3
2013
445
0.190
Why?
Dendritic Cells
2
2016
427
0.190
Why?
Recurrence
4
2017
1139
0.180
Why?
Hepatitis A Virus Cellular Receptor 2
1
2019
5
0.180
Why?
Female
23
2020
44566
0.180
Why?
Galectins
1
2019
9
0.180
Why?
Guidelines as Topic
1
2020
162
0.170
Why?
Hydrazines
1
2019
30
0.170
Why?
Myelodysplastic Syndromes
2
2017
346
0.170
Why?
Mitoxantrone
1
2019
68
0.170
Why?
Fetal Blood
2
2017
90
0.170
Why?
Gene Expression Regulation, Neoplastic
2
2020
1197
0.170
Why?
Interdisciplinary Communication
1
2019
130
0.170
Why?
Clinical Trials as Topic
3
2010
1169
0.170
Why?
Triazoles
1
2019
96
0.170
Why?
Cytarabine
1
2019
218
0.170
Why?
Neoplasm Recurrence, Local
4
2023
1313
0.160
Why?
Proto-Oncogene Proteins c-myc
1
2019
120
0.160
Why?
Melphalan
2
2023
98
0.160
Why?
Proto-Oncogene Proteins c-bcl-2
1
2019
189
0.150
Why?
Treatment Outcome
8
2019
7982
0.150
Why?
Clonal Anergy
2
2008
31
0.150
Why?
Remission Induction
2
2017
722
0.150
Why?
Disease Management
1
2019
328
0.150
Why?
Receptors, Pattern Recognition
1
2017
19
0.150
Why?
Preoperative Care
1
2019
397
0.150
Why?
Patient Care Team
1
2019
280
0.150
Why?
Gene Expression Regulation, Leukemic
2
2015
90
0.150
Why?
Multiple Myeloma
1
2020
307
0.140
Why?
Health Services Misuse
1
2016
19
0.140
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2017
136
0.140
Why?
Drug Therapy, Combination
2
2010
895
0.140
Why?
Xanthones
1
2016
11
0.140
Why?
Receptors, Antigen, T-Cell
4
2016
375
0.140
Why?
Paramyxoviridae
1
2015
10
0.140
Why?
Haploidy
1
2016
31
0.140
Why?
Basic-Leucine Zipper Transcription Factors
1
2016
41
0.140
Why?
Genetic Engineering
1
2016
115
0.130
Why?
Community-Acquired Infections
1
2015
63
0.130
Why?
Immunity
1
2016
137
0.130
Why?
Antibodies, Monoclonal, Humanized
3
2011
931
0.130
Why?
Immunologic Memory
1
2016
152
0.130
Why?
Lymphocyte Subsets
2
2013
64
0.130
Why?
Mitogen-Activated Protein Kinase Kinases
1
2015
101
0.130
Why?
Respiratory Tract Infections
1
2015
105
0.130
Why?
fms-Like Tyrosine Kinase 3
1
2015
127
0.130
Why?
Adaptive Immunity
1
2016
164
0.130
Why?
Receptor, Interferon alpha-beta
1
2014
20
0.130
Why?
Survival Rate
4
2014
1864
0.120
Why?
Inflammation
1
2020
926
0.120
Why?
Enzyme-Linked Immunosorbent Assay
2
2013
378
0.120
Why?
Mice, Transgenic
3
2013
1557
0.120
Why?
Antigens, CD34
4
2017
158
0.120
Why?
Hematopoietic Stem Cell Mobilization
2
2012
50
0.120
Why?
Gene Expression Regulation
2
2017
1928
0.120
Why?
Toll-Like Receptor 9
1
2013
20
0.120
Why?
Interferon-beta
1
2014
125
0.120
Why?
Young Adult
7
2017
5977
0.120
Why?
Haplotypes
2
2013
642
0.120
Why?
Interleukin-18
1
2013
26
0.120
Why?
STAT3 Transcription Factor
1
2013
78
0.110
Why?
Alemtuzumab
3
2011
83
0.110
Why?
Glucocorticoids
1
2015
350
0.110
Why?
Molecular Targeted Therapy
1
2015
266
0.110
Why?
Lymphoma, T-Cell, Peripheral
1
2013
27
0.110
Why?
Transplantation, Haploidentical
3
2017
27
0.110
Why?
Intensive Care Units
1
2016
374
0.110
Why?
Epothilones
1
2013
13
0.110
Why?
Repressor Proteins
1
2016
405
0.110
Why?
Prostate
1
2016
378
0.110
Why?
Drug Resistance, Neoplasm
2
2019
592
0.100
Why?
Combined Modality Therapy
3
2010
1686
0.100
Why?
Neovascularization, Pathologic
1
2014
356
0.100
Why?
Tumor Cells, Cultured
2
2015
1041
0.100
Why?
Hematopoiesis
1
2013
164
0.100
Why?
Angiogenesis Inhibitors
1
2014
311
0.100
Why?
Tissue Donors
2
2012
465
0.100
Why?
Translocation, Genetic
2
2019
265
0.100
Why?
Aged, 80 and over
6
2019
6511
0.100
Why?
Cell Movement
2
2016
762
0.100
Why?
Graft Survival
2
2013
885
0.100
Why?
Protein Kinase Inhibitors
1
2015
589
0.100
Why?
Leukocyte Transfusion
1
2010
15
0.100
Why?
Hospitalization
1
2016
851
0.100
Why?
Cell Survival
1
2013
971
0.090
Why?
Incidence
3
2015
1578
0.090
Why?
Immunomodulation
1
2010
55
0.090
Why?
Graft Rejection
1
2016
1065
0.090
Why?
Apoptosis Regulatory Proteins
1
2010
199
0.090
Why?
Interleukin-2
1
2010
250
0.090
Why?
Stem Cell Transplantation
2
2020
183
0.080
Why?
Antigens, CD
1
2010
459
0.080
Why?
Neoplasm Transplantation
1
2009
392
0.080
Why?
Chimerism
2
2020
37
0.080
Why?
Neoplasm Staging
2
2010
1938
0.080
Why?
Cells, Cultured
1
2013
2839
0.080
Why?
Acute Kidney Injury
1
2011
296
0.080
Why?
Immunosuppressive Agents
2
2015
977
0.080
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2009
173
0.080
Why?
Down-Regulation
1
2009
508
0.080
Why?
Melanoma
1
2011
459
0.070
Why?
Immunity, Cellular
1
2007
179
0.070
Why?
Cyclosporine
1
2007
236
0.070
Why?
Lymphopenia
1
2006
28
0.070
Why?
Models, Animal
1
2007
264
0.070
Why?
Time Factors
2
2013
5215
0.070
Why?
Autoimmune Diseases
1
2007
241
0.070
Why?
Protein Binding
1
2009
1462
0.060
Why?
Neoplasms, Experimental
1
2006
269
0.060
Why?
Prognosis
4
2018
3681
0.060
Why?
Disease Progression
1
2009
1534
0.060
Why?
Age Factors
3
2015
1849
0.060
Why?
Mutation
1
2015
3977
0.060
Why?
Pilot Projects
2
2020
840
0.060
Why?
RNA, Small Interfering
2
2015
547
0.050
Why?
Histocompatibility Testing
2
2017
154
0.050
Why?
Adolescent
3
2016
8988
0.050
Why?
Risk Factors
3
2018
5416
0.050
Why?
Illinois
2
2012
462
0.050
Why?
Health Planning Guidelines
1
2019
24
0.050
Why?
Gene Expression Profiling
1
2006
1387
0.050
Why?
Health Plan Implementation
1
2019
56
0.040
Why?
Standard of Care
1
2019
79
0.040
Why?
Vincristine
1
2019
111
0.040
Why?
Treatment Failure
1
2019
286
0.040
Why?
Prospective Studies
2
2020
4212
0.040
Why?
Maintenance Chemotherapy
1
2019
76
0.040
Why?
Disease-Free Survival
2
2012
1204
0.040
Why?
Etoposide
1
2019
196
0.040
Why?
Prednisone
1
2019
258
0.040
Why?
Preoperative Period
1
2018
90
0.040
Why?
Bone Marrow Cells
1
2019
253
0.040
Why?
Cyclophosphamide
1
2019
299
0.040
Why?
Maximum Tolerated Dose
1
2019
270
0.040
Why?
Doxorubicin
1
2019
295
0.040
Why?
Premedication
1
2017
54
0.040
Why?
Unrelated Donors
1
2017
50
0.040
Why?
Palliative Care
1
2019
257
0.040
Why?
Clinical Decision-Making
1
2019
257
0.040
Why?
T-Lymphocyte Subsets
1
2019
272
0.040
Why?
Cause of Death
1
2018
277
0.040
Why?
Drug Administration Schedule
1
2019
915
0.040
Why?
Feasibility Studies
1
2019
751
0.040
Why?
Receptors, CCR7
1
2016
16
0.040
Why?
B7-2 Antigen
1
2016
40
0.030
Why?
CD8 Antigens
1
2016
82
0.030
Why?
Multiplex Polymerase Chain Reaction
1
2015
33
0.030
Why?
Kaplan-Meier Estimate
1
2018
861
0.030
Why?
Histocompatibility
1
2016
71
0.030
Why?
U937 Cells
1
2015
32
0.030
Why?
Patient Selection
1
2019
686
0.030
Why?
Terminal Care
1
2016
130
0.030
Why?
Comorbidity
1
2018
945
0.030
Why?
Transplant Recipients
1
2015
122
0.030
Why?
Prevalence
1
2018
1240
0.030
Why?
Xenograft Model Antitumor Assays
1
2015
458
0.030
Why?
Bortezomib
1
2013
76
0.030
Why?
Boronic Acids
1
2013
55
0.030
Why?
Mice, Inbred NOD
1
2013
188
0.030
Why?
Immunoglobulin Isotypes
1
2013
32
0.030
Why?
CpG Islands
1
2013
152
0.030
Why?
Pneumococcal Vaccines
1
2013
28
0.030
Why?
Mice, SCID
1
2013
254
0.030
Why?
Mice, Inbred BALB C
1
2015
1059
0.030
Why?
Gene Silencing
1
2013
173
0.030
Why?
Lymphocyte Count
1
2013
94
0.030
Why?
Pyrazines
1
2013
92
0.030
Why?
Killer Cells, Natural
1
2014
267
0.030
Why?
Virus Diseases
1
2013
97
0.030
Why?
Deoxycytidine
1
2013
237
0.030
Why?
Adult Stem Cells
1
2011
30
0.030
Why?
STAT1 Transcription Factor
1
2011
52
0.030
Why?
L-Lactate Dehydrogenase
1
2010
68
0.020
Why?
Family
1
2012
311
0.020
Why?
Glomerular Filtration Rate
1
2011
385
0.020
Why?
Risk
1
2011
674
0.020
Why?
B-Lymphocytes
1
2014
726
0.020
Why?
Lymphatic Metastasis
1
2011
486
0.020
Why?
DNA
1
2015
1295
0.020
Why?
Predictive Value of Tests
1
2014
1672
0.020
Why?
Transcription Factors
1
2016
1580
0.020
Why?
Lymph Nodes
1
2011
533
0.020
Why?
Cohort Studies
1
2014
2765
0.020
Why?
Genes, RAG-1
1
2006
13
0.020
Why?
Lewis X Antigen
1
2006
9
0.020
Why?
Myeloid Progenitor Cells
1
2006
15
0.020
Why?
Expressed Sequence Tags
1
2006
35
0.020
Why?
Adoptive Transfer
1
2006
169
0.020
Why?
Chromosomes, Human, Pair 11
1
2006
106
0.020
Why?
Chromosomes, Human, Pair 9
1
2006
86
0.020
Why?
Gene Library
1
2006
131
0.020
Why?
DNA, Complementary
1
2006
394
0.020
Why?
Leukocytes, Mononuclear
1
2006
196
0.020
Why?
Cost of Illness
1
2005
150
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2006
691
0.010
Why?
Cytokines
1
2006
781
0.010
Why?
Computational Biology
1
2006
528
0.010
Why?
Neoplasm Metastasis
1
2006
1056
0.010
Why?
RNA
1
2006
561
0.010
Why?
RNA, Messenger
1
2006
1988
0.010
Why?
Apoptosis
1
2006
1689
0.010
Why?
Kline's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (290)
Explore
_
Co-Authors (46)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_